Given that T cell exhaustion accompanies PD-1 expression and IFN-γ modulates PD-L1 expression in both immune and tumor cells,24 we speculated that the PD-1 blockade should enhance the therapeutic efficacy of the combination of TLIF-PTT and FlaB-Vax. The gene discussed is CD274; the disease is neoplasm.